Hosted on MSN12h
Alys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trial
US-based immuno-dermatology company Alys Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA ...
Applied Digital Corporation (APLD) Forms Strategic Partnership to Advance AI Computing and Efficiency
We recently compiled a list of the 10 AI News Updates Making Headlines Right Now. In this article, we are going to take a ...
Astellas Pharma Submits NDA For Avacincaptad Pegol For Geographic Atrophy In Japan
(RTTNews) - Astellas Pharma Inc. (ALPMY) Wednesday announced the submission of a New Drug Application or NDA in Japan for Conditional Approval of Avacincaptad Pegol intravitreal solution or ACP for ...
Air Products and Chemicals: Q1 Results Unlikely To Resolve Significant Uncertainty
Air Products and Chemicals' governance changes and activist board seats add uncertainty to its strategic direction. See why ...
D.C. biotech Vanda Pharmaceuticals acquires AnaptysBio’s drug for rare skin disorder
D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...
APLT INVESTOR DEADLINE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
February 4, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, both ...